Schonfeld Strategic Advisors’s Dyne Therapeutics DYN Stock Holding History

Schonfeld Strategic Advisors’s Portfolio DYN Stock Details DYN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.99M	Buy	+134,752	New	+$2.51M	0.01%	865
2025 Q4	–	Sell	-415,927	Closed	-$5.26M	–	2177
2025 Q3	$5.26M	Buy	415,927 +82,474	+25%	+$941K	0.03%	565
2025 Q2	$3.17M	Buy	333,453 +187,159	+128%	+$2.06M	0.02%	757
2025 Q1	$1.53M	Buy	+146,294	New	+$2.09M	0.01%	1087
2024 Q4	–	Sell	-36,352	Closed	-$1.31M	–	2100
2024 Q3	$1.31M	Sell	36,352 -78,843	-68%	-$3.14M	0.01%	1066
2024 Q2	$4.07M	Sell	115,195 -154,562	-57%	-$4.49M	0.03%	623
2024 Q1	$7.66M	Sell	269,757 -5,942	-2%	-$134K	0.05%	474
2023 Q4	$3.67M	Buy	+275,699	New	+$2.69M	0.02%	600

Other funds holding DYN

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

OAG

Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return

AVLSA

Atlas Venture Life Science Advisors Cambridge, Massachusetts $881M AUM 160.77% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

TCM

TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Schonfeld Strategic Advisors's DYN Position: Q2 2026 in Review

Schonfeld Strategic Advisors opened a new position in Dyne Therapeutics (DYN) in Q2 2026: 134,752 shares worth $2.99M. The stake represents 0.01% of the portfolio and ranks #865 among its holdings. This is a return to the name: Schonfeld Strategic Advisors previously reported a position in DYN as recently as Q3 2025.

Schonfeld Strategic Advisors first reported a position in DYN in Q4 2023 and has held it in 8 quarters since. The position peaked at $7.66M in Q1 2024. 245 funds tracked by Wall St. Rank hold DYN as of Q2 2026.

Schonfeld Strategic Advisors held 134,752 shares of Dyne Therapeutics worth $2.99M as of Q2 2026.
Dyne Therapeutics was a new Schonfeld Strategic Advisors position in Q2 2026.
Dyne Therapeutics made up 0.01% of Schonfeld Strategic Advisors's portfolio in Q2 2026, its #865 holding.
Schonfeld Strategic Advisors first reported a position in Dyne Therapeutics in Q4 2023 and has held it in 8 quarters since.
Schonfeld Strategic Advisors's Dyne Therapeutics position peaked at $7.66M in Q1 2024.
245 funds tracked by Wall St. Rank held Dyne Therapeutics as of Q2 2026.

Based on Schonfeld Strategic Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.